Alex Rogers, Executive Producer of the International Cannabis Business Conference, welcomes conference attendees and provides an overview of the conference schedule, including the panels and speakers that will be providing presentations and interviews. Ngaio Bealum will be the Master of Ceremonies.

Delve into the complex world of cannabinoid regulations in foodstuff in the EU. This discussion looks at the implementation and enforcement of regulations pertaining to Cannabinoids in food products, unravelling the diverse approaches adopted by EU member states. Explore the complexity between regional regulations and overarching EU guidelines, shedding light on the disparities within the union. From varied national perspectives to harmonization and authorization attempts within the EU, we will dissect the challenges of establishing novel food status for hemp food ingredients and cannabinoids – including ongoing side challenges with health claims, novel cannabinoids like HHC or 4HCBD and inappropriate marketing. Join us to gain insights into the legal complexities surrounding the risk assessment of cannabinoids, an issue that extends far beyond culinary preferences.

Cannabinoid research is one of the most exciting areas of the cannabis science field, with new information being discovered about the potential therapeutic benefits of cannabinoids on a seemingly frequent basis. As we learn more about the cannabinoids that make up the cannabis plant and their unique qualities, research must be conducted with a focus on applying knowledge toward developing wellness products and cannabis therapies for patients. This panel will discuss the unique challenges facing the cannabinoid research field, results from recent research efforts, and what the future may hold for therapeutic applications of cannabinoids.

We currently live in the most exciting time in human history for cannabis research, thanks in large part to eroding prohibition policies around the world and the emergence of the international medical cannabis industry. Demand for cannabinoid-based pharmaceutical products is greater now than ever before, and with more countries modernizing their cannabis policies to permit the research and development of such products, the future is very bright for the cannabinoid pharmaceutical sector. This panel is dedicated to discussing the future of cannabinoid-based pharmaceutical research and product development.

The panel offers provides an in-depth exploration into the multifaceted and complex dynamics surrounding the emergence of cannabis as a commodity in the agri-industry, conventional pharmaceuticals, and fast-moving consumer goods (FMCG). What role does cannabis play as a commodity, as it integrates into established sectors? Our panelists will examine practical challenges and promising opportunities and explore the evolving agricultural practices, the nuanced changes in pharmaceutical approaches, and the shifting dynamics of consumer goods influenced by this green revolution. It is an opportunity to engage in an insightful conversation about the various aspects of cannabis as it gradually establishes itself as a versatile commodity of the future, shaping industries and prompting a reevaluation of traditional norms.

The legal international cannabis industry is young by every measure, and many nations are still working to overhaul their cannabis policies and industry regulations. Currently, the legal industry landscape is dominated by a handful of nations, however, the landscape is guaranteed to evolve in the coming years as more markets enter the global arena. Oceania, Latin America, and certain European markets are well-positioned to harness their domestic resources to gain a meaningful share of the global market. Panelists will discuss which markets may hold the most potential in the short and long term, and what sectors of the industry people should focus on going forward.